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Abstract
Nudges — which present information or set choices to achieve desired behavior — increased guideline
based statin prescribing over usual care. Clinician nudges alone had a small effect, patient nudges alone
had no effect, and combined clinician and patient nudges had the greatest effect, increasing prescribing
by 7.2 percentage points. The interventions employed a common electronic health record (EHR) system,
making them generalizable and scalable.
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Key Findings

Nudges — which present information or set choices to achieve desired behavior — increased guidelinebased statin prescribing over usual care. Clinician nudges alone had a small effect, patient nudges alone had
no effect, and combined clinician and patient nudges had the greatest effect, increasing prescribing by 7.2
percentage points. The interventions employed a common electronic health record (EHR) system, making
them generalizable and scalable.
THE RESEARCH QUESTION
Cardiovascular disease is the leading cause of death in the
U.S. Statins, cholesterol-lowering drugs, are recommended
for most people with cardiovascular disease, as they
significantly reduce risk of cardiovascular events and related
morbidity and mortality. Despite this, many people eligible
for statins based on current guidelines do not receive them
from their clinician.
Nudges are a promising approach to increase the use of
medications such as statins. Typically, nudges are small
changes in the way information is framed or in the choices
offered to patients and clinicians. Despite the small
changes, nudges can have a surprisingly large impact on
behavior, including medication prescribing.
In this study, the authors conducted a randomized
controlled trial to test the effect of nudges on statin
prescribing. The nudges were aimed at patients, at

clinicians, and at the combination of the two, and the
researchers examined which approach worked best to
increase statin prescribing.

THE FINDINGS
When the nudges were aimed at clinicians, statin
prescribing increased by 5.5 percentage points compared to
usual care. Nudges were also effective at increasing statin
use when they targeted a combination of clinicians and
patients. In that case, statin prescribing increased by 7.2
percentage points. When the nudges were aimed at patients
alone, statin prescribing did not significantly change.
During a 12-month preintervention period, in unadjusted
analyses, the rate of new statin prescribing at visits was
under 5% in some study arms. With both clinician and
patient nudges, new statin prescribing rose to as high as
16% for eligible patients not already taking a statin. The trial
had no serious adverse events.
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Combining patient and clinician nudges synergistically
changed prescribing behavior to increase guideline-directed
care. The clinician nudges were automated in a widely used
EHR, so they are scalable, pragmatic, and a template for
making nudges a standard feature of health care. EHRbased nudges can be add-ons to a delivery system’s EHR
or could become a foundational technology of health IT
systems, after rigorous evaluation and in collaboration with
EHR vendors.
Digital companies such as Netflix, Amazon, and Facebook
effectively nudge users into desired behavior. Automated
EHR-based nudges use the same digital strategies to make
guideline-based care easy, by presenting the right information
to the right person at the right point in the workflow.
Lessons for Future Interventions
This study’s nudge intervention is a model for effective
health IT implementation design, involving collaboration
between the research team, primary care practices, and
health system IT team. The clinician nudge was cocreated
with clinicians in an iterative process to ensure uptake and
an intuitive user experience.
The results indicate that nudging clinicians in conjunction
with patients may be most effective in altering behavior.
Further more, clinician peer comparison feedback
establishes norms and benchmarks for desired behavior, and
EHR prompts provide a way to act according to the norms
established by peer comparisons.
Additional work in progress includes a qualitative report on
patient perceptions of the statin text message nudges.

Figure 1. Statin Prescribing Relative to Usual Care
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patient visits, plus a monthly feedback report showing
statin prescribing of the clinician compared to their peers.
Patient nudges were text messages sent a few days before
a primary care visit about the risks and benefits of statins
with a suggestion to discuss them at their upcoming visit.
Researchers monitored statin prescribing in the randomized
practices over the preintervention and six-month
intervention period from October 2019 to April 2021.
Practices in the study saw a patient group that included
4,131 individuals. Among those, 66% were white and 29%
were Black, the average age was 66 years, and 23% had
atherosclerotic cardiovascular disease. The primary outcome
was initiation of a statin prescription during the visit.

THE STUDY
The authors determined the effect of nudges on statin
prescribing by randomizing 28 primary care practices to
one of four options: usual care; clinician nudge; patient
nudge; or clinician and patient nudges. The primary care
practices were part of the University of Pennsylvania Health
System, where about 70% of eligible patients had statin
prescriptions. The study focused on the remaining patients.
Clinician nudges were implemented in an EHR prompt
to order or not order statins for eligible patients during
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